Shuyu E
Overview
Explore the profile of Shuyu E including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
356
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu J, Kim D, Wang W, Li S, Lin P, Tang G, et al.
Am J Clin Pathol
. 2024 Sep;
163(2):240-250.
PMID: 39244687
Objectives: Acute myeloid leukemia (AML) with mast cell (MC) differentiation was recently described as an aggressive subgroup of AML cases. The objectives of this study were to assess the flow...
2.
E S, Nahmod K, Thakral B, Wang W, Jorgensen J, Wang S
Cytometry B Clin Cytom
. 2024 Sep;
PMID: 39237839
No abstract available.
3.
E S, Xu J, Wang S, Tang G, Jabbour E, Li S, et al.
Am J Clin Pathol
. 2024 Sep;
163(2):231-239.
PMID: 39235991
Objectives: The blasts in most cases of chronic myeloid leukemia blast phase (CML-BP) have a myeloid or precursor-B immunophenotype, with only a small subset having T-cell or natural killer-cell lineage....
4.
E S, Tang G, Li S, Schlette E, Wang S, Xu J
Int J Lab Hematol
. 2024 Aug;
47(1):13-14.
PMID: 39109887
No abstract available.
5.
Alqahtani S, Ramakrishnan R, E S, Wang S, Nunez C, McCall D, et al.
Pediatr Blood Cancer
. 2024 Jun;
71(8):e31123.
PMID: 38837565
No abstract available.
6.
Rivera D, Cui W, Gao J, Peker D, Zhang Q, Dewar R, et al.
Mod Pathol
. 2023 Dec;
37(2):100406.
PMID: 38104892
Chronic myeloid leukemia (CML) is characterized by leukocytosis with left-shifted neutrophilia, basophilia, eosinophilia, and variable thrombocytosis. However, extremely rare cases of patients with CML without significant leukocytosis and thrombocytosis (aleukemic...
7.
Lin J, Rodriguez-Martinez P, Oo T, E S, Jorgensen J, Rojas-Hernandez C
J Immunother
. 2023 Oct;
PMID: 37904601
Immune checkpoint inhibitors (ICI) have gained approval as a treatment for a wide array of cancers. Their mechanism of action prevents the inactivation of cytotoxic T-cells, allowing for its cytotoxic...
8.
E S, Nahmod K, Wang S, Yin C
Int J Lab Hematol
. 2023 Sep;
46(1):5-7.
PMID: 37674279
No abstract available.
9.
Dacheux M, Lee S, Shin Y, Norman D, Lin K, E S, et al.
Cancers (Basel)
. 2022 Mar;
14(6).
PMID: 35326737
Although metastases are the principal cause of cancer-related deaths, the molecular aspects of the role of stromal cells in the establishment of the metastatic niche remain poorly understood. One of...
10.
Xu H, Zhao X, Bhojwani D, E S, Goodings C, Zhang H, et al.
Clin Cancer Res
. 2019 Oct;
26(1):256-264.
PMID: 31573954
Purpose: Treatment outcomes for childhood acute lymphoblastic leukemia (ALL) have improved steadily, but a significant proportion of patients still experience relapse due to drug resistance, which is partly explained by...